By SHARON K. GILBERT April 27, 2009 ONE YEAR AGO, nearly to the day before a woman (patient zero?) presented to hospital staff in Ouaxaca, Mexico (on April 3, 2009) with ‘atypical pneumonia’ and died, a Boston based biotech company published a press release predicting the strong likelihood of anContinue Reading